51 | 3KQD |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
1-(3-(5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-6-(2'-(PYRROLIDIN-1-YLMETHYL)BIPHENYL-4-YL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE |
LGL |
|
0.83 |
SHOW |
52 | 2VVC |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
5-chloro-N-[(3S,4S)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)-4-methoxypyrrolidin-3-yl]thiophene-2-carboxamide |
LZF |
|
0.83 |
SHOW |
53 | 2BQ7 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE |
IID |
|
0.83 |
SHOW |
54 | 1J17 |
Anionic trypsin-2 | Rattus norvegicus |
P00763 (TRY2_RAT) |
[4-(6-CHLORO-NAPHTHALENE-2-SULFONYL)-PIPERAZIN-1-YL]- (3,4,5,6-TETRAHYDRO-2H-[1,4']BIPYRIDINYL-4-YL)- METHANONE |
ZEN |
|
0.83 |
SHOW |
55 | 2Y5F |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(3AS,4R,5S,8AS,8BR)-4-[5-(5-CHLOROTHIOPHEN-2-YL)-1,2-OXAZOL-3-YL]-2-[3-[1-(2-HYDROXYETHYL)PYRROLIDIN-1-IUM-1-YL]PROPYL]-4,6,7,8,8A,8B-HEXAHYDRO-3AH-PYRROLO[3,4-A]PYRROLIZINE-1,3-DIONE |
XWG |
|
0.82 |
SHOW |
56 | 1IQK |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE |
XMI |
|
0.82 |
SHOW |
57 | 1IQG |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-1-[[4-HYDROXYIMINOMETHYL-1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE |
XME |
|
0.82 |
SHOW |
58 | 1NFY |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE |
RTR |
|
0.82 |
SHOW |
59 | 1IOE |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(-)-7-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]TETRAHYDRO-8A-(METHOXYMETHYL)-1'-(4-PYRIDINYL)-SPIRO[5H-OXAZOLO[3,2-A]PYRAZINE-2(3H),4'-PIPERIDIN]-5-ONE |
XMA |
|
0.82 |
SHOW |
60 | 4Y6D |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(3S)-3-({[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonyl}amino)-2-oxopyrrolidin-1-yl]-3-fluoro-N,N-dimethylbenzamide |
48U |
|
0.82 |
SHOW |
61 | 3Q3K |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
N-(2-{[(5-chloro-1H-indol-2-yl)carbonyl]amino}phenyl)-5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carboxamide |
D90 |
|
0.82 |
SHOW |
62 | 4Y7B |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
6-chloro-N-{(3S)-1-[(2S)-1-{(1R,5S)-7-[2-(methylamino)ethyl]-3,7-diazabicyclo[3.3.1]non-3-yl}-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide |
44I |
|
0.82 |
SHOW |
63 | 4ZHA |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(3S)-3-({[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonyl}amino)-2-oxo-2,3-dihydro-1H-pyrrol-1-yl]-3-fluoro-N-methylbenzamide |
4O5 |
|
0.82 |
SHOW |
64 | 1LQD |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
1-(3-CARBAMIMIDOYL-BENZYL)-4-METHYL-1H-INDOLE-2-CARBOXYLIC ACID 3,5-DIMETHYL-BENZYLAMIDE |
CMI |
|
0.82 |
SHOW |
65 | 1EZQ |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
3-[(3'-AMINOMETHYL-BIPHENYL-4-CARBONYL)-AMINO]-2-(3-CARBAMIMIDOYL-BENZYL)-BUTYRIC ACID METHYL ESTER |
RPR |
|
0.82 |
SHOW |
66 | 3TK5 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-{3-[(4-chlorophenyl)amino]-3-oxopropyl}-3-({[5-(propan-2-yl)-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl]carbonyl}amino)benzoic acid |
D1Q |
|
0.82 |
SHOW |
67 | 2PHB |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(2R,4R)-N~1~-(4-CHLOROPHENYL)-N~2~-[2-FLUORO-4-(2-OXOPYRIDIN-1(2H)-YL)PHENYL]-4-METHOXYPYRROLIDINE-1,2-DICARBOXAMIDE |
230 |
|
0.82 |
SHOW |
68 | 2Q1J |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
1-(butyl{[(4-chlorophenyl)amino]carbonyl}amino)-N-[3-fluoro-2'-(methylsulfonyl)biphenyl-4-yl]cyclopropanecarboxamide |
FXI |
|
0.81 |
SHOW |
69 | 2BMG |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
3-[2-(2,4-DICHLOROPHENYL)ETHOXY]-4-METHOXY-N-[(1-PYRIDIN-4-YLPIPERIDIN-4-YL)METHYL]BENZAMIDE |
I1H |
|
0.81 |
SHOW |
70 | 3CEN |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE |
FXA |
|
0.81 |
SHOW |
71 | 2W3I |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(2R,4S)-N^1^-(4-chlorophenyl)-4-(2,4-difluorophenyl)-4-hydroxy-N^2^-(2-oxo-2H-1,3'-bipyridin-6'-yl)pyrrolidine-1,2-dicarboxamide |
L1C |
|
0.81 |
SHOW |
72 | 1MQ6 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
3-CHLORO-N-[4-CHLORO-2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2-OXAZOLYL)METHYLAMINO]METHYL]-2-THIOPHENECARBOXAMIDE |
XLD |
|
0.81 |
SHOW |
73 | 2XC5 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(3R,4R)-1-METHANESULFONYL-PYRROLIDINE-3,4-DICARBOXYLIC ACID 3-[(4-CHLORO-3-FLUORO-PHENYL)-AMIDE] 4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE} |
OYJ |
|
0.81 |
SHOW |
74 | 2W3K |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(2R,4S)-N^1^-(4-chlorophenyl)-N^2^-[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]-4-hydroxy-4-phenylpyrrolidine-1,2-dicarboxamide |
L1D |
|
0.8 |
SHOW |
75 | 2BOK |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
[AMINO (4-{(3AS,4R,8AS,8BR)-1,3-DIOXO-2- [3-(TRIMETHYLAMMONIO) PROPYL]DECAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL}PHENYL) METHYLENE]AMMONIUM |
784 |
|
0.8 |
SHOW |
76 | 2P95 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE |
ME5 |
|
0.8 |
SHOW |
77 | 1IQJ |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]-2-PIPERAZINECARBOXYLIC ACID ETHYL ESTER |
XMH |
|
0.8 |
SHOW |
78 | 1NFX |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-1-{[1-(2-HYDROXYETHYL)-1H-PYRROLO[3,2-C]PYRIDIN-2-YL]METHYL}PIPERAZIN-2-ONE |
RDR |
|
0.8 |
SHOW |
79 | 2XBX |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(3R,4R)-1-METHANESULFONYL-PYRROLIDINE-3,4-DICARBOXYLIC ACID 3-[(4-CHLORO-PHENYL)-AMIDE] 4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE} |
RR8 |
|
0.79 |
SHOW |
80 | 2Y5G |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
3-[(3AS,4R,5S,8AS,8BR)-4-[5-(5-CHLOROTHIOPHEN-2-YL)-1,3-OXAZOL-2-YL]-1,3-DIOXO-4,6,7,8,8A,8B-HEXAHYDRO-3AH-PYRROLO[3,4-A]PYRROLIZIN-2-YL]PROPYL-TRIMETHYL-AZANIUM |
FJD |
|
0.79 |
SHOW |
81 | 2XBV |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(3R,4R)-1-(2,2-DIFLUORO-ETHYL)-PYRROLIDINE-3,4-DICARBOXYLIC ACID 3-[(5-CHLORO-PYRIDIN-2-YL)-AMIDE]-4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE} |
XBV |
|
0.79 |
SHOW |
82 | 2XBY |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(3R,4R)-1-METHYLCARBAMOYLMETHYL-PYRROLIDINE-3,4-DICARBOXYLIC ACID 3-[(4-CHLORO-PHENYL)-AMIDE] 4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE} |
63C |
|
0.79 |
SHOW |
83 | 1Y5U |
Cationic trypsin | Bos taurus |
P00760 (TRY1_BOVIN) |
2-O-{3-[AMINO(IMINO)METHYL]PHENYL}-5-O-{4-[AMINO(IMINO)METHYL]PHENYL}-1,4:3,6-DIANHYDRO-D-GLUCITOL |
TL4 |
|
0.79 |
SHOW |
84 | 3FFG |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(R)-6-(2'-((3-hydroxypyrrolidin-1-yl)methyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h-1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-5,6-dihydro-1h-pyrazolo[3,4-c]pyridin-7(4h)-one |
FFG |
|
0.78 |
SHOW |
85 | 2XBW |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(3R,4R)-1-SULFAMOYL-PYRROLIDINE-3,4-DICARBOXYLIC ACID 3-[(4-CHLORO-PHENYL)-AMIDE] 4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE} |
455 |
|
0.78 |
SHOW |
86 | 4O9V |
Suppressor of tumorigenicity 14 protein | Homo sapiens |
Q9Y5Y6 (ST14_HUMAN) |
N-(trans-4-aminocyclohexyl)-3,5-bis(4-carbamimidoylphenoxy)benzamide |
NT4 |
|
0.77 |
SHOW |
87 | 1V2K |
Cationic trypsin | Bos taurus |
P00760 (TRY1_BOVIN) |
[4-(6-CHLORO-NAPHTHALENE-2-SULFONYL)-PIPERAZIN-1-YL]- (3,4,5,6-TETRAHYDRO-2H-[1,4']BIPYRIDINYL-4-YL)- METHANONE |
ZEN |
|
0.77 |
SHOW |
88 | 3M37 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
1-[2-(aminomethyl)phenyl]-N-(3-fluoro-2'-sulfamoylbiphenyl-4-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide |
M37 |
|
0.77 |
SHOW |
89 | 1Y5A |
Cationic trypsin | Bos taurus |
P00760 (TRY1_BOVIN) |
2-O-{4-[AMINO(IMINO)METHYL]PHENYL}-5-O-{3-[AMINO(IMINO)METHYL]PHENYL}-1,4:3,6-DIANHYDRO-D-GLUCITOL |
TL2 |
|
0.76 |
SHOW |
90 | 2XC0 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(3R,4R)-1-METHANESULFONYL-PYRROLIDINE-3,4--DICARBOXYLIC ACID 3-[(3-FLUORO-4-METHOXY-PHENYL)-AMIDE] 4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE} |
8NC |
|
0.75 |
SHOW |
91 | 6T7H |
Prothrombin | Homo sapiens |
P00734 (THRB_HUMAN) |
macrocycle N14-PR4-A |
MRQ |
|
0.73 |
SHOW |
92 | 1F0S |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE |
PR2 |
|
0.7 |
SHOW |
93 | 4LXB |
Prothrombin | Homo sapiens |
P00734 (THRB_HUMAN) |
5-Chloro-thiophene-2-carboxylic acid [(S)-2-[2-difluoromethoxy-3-(2-oxo-piperidin-1-yl)-benzenesulfonylamino]-3-((S)-3-dimethylamino-pyrrolidin-1-yl)-3-oxo-propyl]-amide |
7R9 |
|
0.69 |
SHOW |
94 | 4LOY |
Prothrombin | Homo sapiens |
P00734 (THRB_HUMAN) |
5-Chloro-thiophene-2-carboxylic acid [(S)-2-[2-chloro-5-fluoro-3-(2-oxo-piperidin-1-yl)-benzenesulfonylamino]-3-(4-methyl-piperazin-1-yl)-3-oxo-propyl]-amide |
6XS |
|
0.69 |
SHOW |
95 | 4YZU |
Coagulation factor IX | Homo sapiens |
P00740 (FA9_HUMAN) |
N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-4-(4H-1,2,4-triazol-4-yl)benzamide |
4K6 |
|
0.64 |
SHOW |
96 | 1W7G |
Prothrombin | Homo sapiens |
P00734 (THRB_HUMAN) |
N-{(1S)-1-{[4-(3-AMINOPROPYL)PIPERAZIN-1-YL]CARBONYL}-4-[(DIAMINOMETHYLENE)AMINO]BUTYL}-3-(TRIFLUOROMETHYL)BENZENESULFONAMIDE |
MIU |
|
0.63 |
SHOW |
97 | 5TJX |
Plasma kallikrein | Homo sapiens |
P03952 (KLKB1_HUMAN) |
(8E)-3-amino-1-methyl-15-[(1H-pyrazol-1-yl)methyl]-7,10,11,12,24,25-hexahydro-6H,18H,23H-19,22-(metheno)pyrido[4,3-j][1,9,13,17,18]benzodioxatriazacyclohenicosin-23-one |
GBT |
|
0.59 |
SHOW |